ArticleBlood2022

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.

Nicolas Duployez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.